Frigate Ventures »

Iovance Biotherapeutics shares owned by Frigate Ventures

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Frigate Ventures from 13F filings

Historical chart of Frigate Ventures investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Frigate Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Frigate Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $910k 200k 4.55

More positions owned by Frigate Ventures

Tempur Sealy International Equity (TPX)
AdvisorShares Pure US Cannabis ETF Exchange Traded Fund (MSOS)
Nano Dimension Adr (NNDM)
Blockchain Coinvestors Acquisition Corp I Warrant (BCSAW)
iShares U.S. Real Estate ETF Exchange Traded Fund (IYR)
iShares 20 Year Treasury Bond ETF Option Call Option (TLT)
SPDR S&P 500 ETF Trust Option Put Option (SPY)
iShares iBoxx High Yield Corporate Bond ETF Option Put Option (HYG)
Block Option Call Option (SQ)
Activision Blizzard Equity
Oncolytics Biotech Equity (ONCY)
Vivid Seats Equity (SEAT)
iShares China Large-Cap ETF Option Call Option (FXI)
Invesco QQQ Trust Series 1 Option Put Option (QQQ)
Tricon Residential Option Call Option (TCN)

View all positions for Frigate Ventures

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Balyasny Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
Credit Suisse
Long Focus Capital Management
Palo Alto Investors
Caption Management

View all funds holding Iovance Biotherapeutics